| M | T | W | T | F | S | S | |
|---|---|---|---|---|---|---|---|
 | 1 | 2 | 3 | 4 | 5 | 6 | 7 |
| 8 | 9 | 10 | 11 | 12 | 13 | 14 |
| 15 | 16 | 17 | 18 | 19 | 20 | 21 |
| 22 | 23 | 24 | 25 | 26 | 27 | 28 |
| 29 | 30 | 31 |
VIRAX HOLDINGS LIMITED (VHL)
Stock Code: VHL
Listing Date: 1986-12-19 00:00:00
Website: http://www.virax.com.au/
Industry: Pharmaceuticals, Biotechnology & Life Sciences
Principal Activities:
Bio-pharmaceutical research and development investment.
Address:
89 High Street, Suite 220
KEW
VIC 3101
Phone: (03) 9854 6230
Fax: (03) 9853 5134
Executives & Directors
Mr Michael Humphris, Chairman, Non Exec. Director
Dr Larry Ward, CEO
Mr Ian Pyman, Non Exec. Director
Dr Albert King, Non Exec. Director
Mr John Morrison, CFO
Company Podcasts
Subscribe to current and future audio events for this company by clicking on the podcast icon:
Company ASX Announcements
Company ASX announcements can be viewed on the ASX website.
Announcements from the preceding six months are shown below.
Click here to view this company's details on the ASX site
Company Events
VHL - Commencement of Phase II US trials - Dr David Beames, CEO
|
|
Mon, 20 Nov 2006 11:00AM |
| Annual General Meeting | Wed, 26 Nov 2008 02:30PM |
|
| Full Year Results | Fri, 29 Aug 2008 | |
| Interim Results | Thu, 28 Feb 2008 | |
| Annual General Meeting | Tue, 27 Nov 2007 11:00AM |
|
| Full Year Results | Thu, 30 Aug 2007 | |
| Interim Results | Wed, 28 Feb 2007 | |
| Full Year Results | Thu, 17 Aug 2006 | |
| Interim Results | Thu, 16 Mar 2006 | |
| Annual General Meeting | Mon, 21 Nov 2005 10:48AM |
VIRAX HOLDINGS LIMITED (VHL)
| Transgene Trial Results | Tue, 3 Jun 2008 |
| Form 603 and 605 from ANZ | Mon, 12 May 2008 |
| Convertible Notes and Quarterly Report to Trust and ASIC | Wed, 30 Apr 2008 |
| Shareholding update and Convertible Note Placement | Tue, 29 Apr 2008 |
| ANZ: Opes Prime Disclosure | Thu, 17 Apr 2008 |
| ANZ: Opes Prime Disclosure | Wed, 16 Apr 2008 |
| ANZ: Opes Prime Disclosure | Tue, 15 Apr 2008 |
| ANZ: Opes Prime Disclosure | Mon, 14 Apr 2008 |
| ANZ: Opes Prime Disclosure | Fri, 11 Apr 2008 |
| ANZ: Opes Prime Disclosure | Thu, 10 Apr 2008 |
| ANZ: Opes Prime Disclosure | Wed, 9 Apr 2008 |
| ANZ: Opes Prime Disclosure | Tue, 8 Apr 2008 |
| ANZ: Opes Prime Disclosure | Mon, 7 Apr 2008 |
| Letter to Shareholders - Prospectus 19 December 2007 | Fri, 21 Dec 2007 |
| Prospectus - 19 December 2007 | Wed, 19 Dec 2007 |
| Prospectus, Licence Valuation and Appointment of CEO | Wed, 19 Dec 2007 |
| Appendix 3B - Prospectus - 19 December 2007 | Wed, 19 Dec 2007 |
| Appendix 3Z | Mon, 3 Dec 2007 |
| Capital Raising | Tue, 27 Nov 2007 |
| AGM Results | Tue, 27 Nov 2007 |
| Chairman and CEO Address and Presentation at AGM | Tue, 27 Nov 2007 |
| Notice of AGM | Fri, 26 Oct 2007 |
| Annual Report 2007 | Fri, 28 Sep 2007 |
| Electronic Distribution of Annual Report | Thu, 20 Sep 2007 |
| Virax Announces Grant of Key VIR201 Patent in Europe | Wed, 19 Sep 2007 |
| Appendix 4E | Thu, 30 Aug 2007 |
| VHL Milestone Payment from Transgene | Thu, 23 Aug 2007 |
| Publication of VIR201 Phase IIa Trial Results | Wed, 18 Jul 2007 |
| Allowance of Key VIR201 Patent in the US | Tue, 10 Jul 2007 |
| Appendix 3B | Thu, 5 Jul 2007 |
Please note: This company appears on this website as a result of its listing on the Australian Securities Exchange. Boardroom Radio does not claim any association with any company listed on this site.